Abstract
A new and facile one-pot synthesis of the biologically important spiro[quinazoline/pyrimidine]ones scaffold was synthesized simply by the reaction of isatin, 1,3-dione and urea or thiourea. The scope of the reaction was successfully extended by employing two other reactive ketones (acenaphthylene-1,2-dione and ninhydrin) instead of isatin. A series of new spiro cyclic derivatives via multi-component reaction was obtained by using guanidine and employing different 1,3 - dicarbonyl compounds.
Keywords: Acenaphthylene-1, 2-dione, 1, 3-Dicarbonyls, dihydropyrimidinone, isatin, multi-component reaction, ninhydrin, spiroheterocycles.
Letters in Organic Chemistry
Title:One-Pot Synthesis of Novel Spiro[quinazoline/pyrimidine]ones via Multi Component Reaction
Volume: 10 Issue: 6
Author(s): Gangadhar Meshram, Pramod Wagh, Shruti Deshpande and Vipul Amratlal
Affiliation:
Keywords: Acenaphthylene-1, 2-dione, 1, 3-Dicarbonyls, dihydropyrimidinone, isatin, multi-component reaction, ninhydrin, spiroheterocycles.
Abstract: A new and facile one-pot synthesis of the biologically important spiro[quinazoline/pyrimidine]ones scaffold was synthesized simply by the reaction of isatin, 1,3-dione and urea or thiourea. The scope of the reaction was successfully extended by employing two other reactive ketones (acenaphthylene-1,2-dione and ninhydrin) instead of isatin. A series of new spiro cyclic derivatives via multi-component reaction was obtained by using guanidine and employing different 1,3 - dicarbonyl compounds.
Export Options
About this article
Cite this article as:
Meshram Gangadhar, Wagh Pramod, Deshpande Shruti and Amratlal Vipul, One-Pot Synthesis of Novel Spiro[quinazoline/pyrimidine]ones via Multi Component Reaction, Letters in Organic Chemistry 2013; 10 (6) . https://dx.doi.org/10.2174/1570178611310060006
DOI https://dx.doi.org/10.2174/1570178611310060006 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Analgesia in PACU: Nonsteroidal Anti-Inflammatory Drugs
Current Drug Targets Mediterranean Diet and Risk of Dementia
Current Alzheimer Research Causes and Effects of Cellular Oxidative Stress as a Result of MDMA Abuse
Current Pharmaceutical Biotechnology The Genetics and Genomics of Systemic Sclerosis: An Update and Review
Current Rheumatology Reviews How Recent Patents Have Changed our Clinical Approach in Cardio-Thoracic Surgery
Recent Patents on Regenerative Medicine Urine Albumin/Creatinine Ratio, High Sensitivity C-Reactive Protein and N-Terminal Pro Brain Natriuretic Peptide - Three New Cardiovascular Risk Markers - Do They Improve Risk Prediction and Influence Treatment?
Current Vascular Pharmacology Editorial [Hot topic: Adenosine Receptor Ligands: Where Are We, and Where Are We Going? (Guest Editors: Tiziano Tuccinardi and Adriano Martinelli)]
Current Topics in Medicinal Chemistry Ketamine: New Indications for an Old Drug
Current Drug Targets Anti-inflammatory Treatment of Acute Coronary Syndromes
Current Pharmaceutical Design Rational Basis for Nutraceuticals in the Treatment of Glaucoma
Current Neuropharmacology Oxidative-Nitrosative Stress as a Contributing Factor to Cardiovascular Disease in Subjects with Diabetes
Current Vascular Pharmacology Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
Current Drug Targets Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Vasopressin-Receptor Antagonists: A New Class of Agents for the Treatment of Hyponatremia
Endocrine, Metabolic & Immune Disorders - Drug Targets Interaction of Cyclosporine A and the Renin-Angiotensin System New Perspectives
Current Drug Metabolism Increased Risk of Cardiovascular Complications in Chronic Kidney Disease: A Possible Role of Leptin
Current Pharmaceutical Design Standards and Novel Therapeutic Options in the Treatment of Patients with Soft Tissue Sarcoma
Reviews on Recent Clinical Trials The Prevalence of Frailty in Patients Admitted to Hospital with Vertebral Fragility Fractures
Current Rheumatology Reviews The Vasoactive Role of Nitric Oxide: Physiological and Morphological Aspects
Current Pharmaceutical Biotechnology Management of Primary Aldosteronism: Its Complications and Their Outcomes After Treatment
Current Vascular Pharmacology